Tsukuba, Japan

Mio Takada

This inventor holds 1 USPTO granted patent. Top assignee: Smithkline Beecham Corporation. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mio Takada. Retrieved from https://idiyas.com/inventor/mio-takada

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mio Takada: Innovator in Chemical Compounds

Introduction

Mio Takada is a prominent inventor based in Tsukuba, Japan. She has made significant contributions to the field of chemical compounds, particularly in the development of inhibitors for kinases. Her work aims to address various disorders through innovative solutions.

Latest Patents

Mio Takada holds a patent related to newly identified inhibitors of kinases. This invention is crucial for treating a range of disorders, showcasing her expertise and dedication to advancing medical science. She has 1 patent to her name, reflecting her innovative spirit.

Career Highlights

Mio Takada is currently employed at SmithKline Beecham Corporation, where she continues to push the boundaries of research and development. Her role at the company allows her to collaborate with other talented professionals in the field.

Collaborations

Some of her notable coworkers include Hideyuki Sato and Yoshiaki Washio. Together, they contribute to the advancement of their projects and share a commitment to innovation in their respective areas.

Conclusion

Mio Takada's work in the field of chemical compounds exemplifies her dedication to improving healthcare through innovative inventions. Her contributions are vital in the ongoing quest to develop effective treatments for various disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…